A
B
Budget Impact Analysis (BIA) / Budget Impact Model (BIM)
C
Cost Minimisation Analysis (CMA)
Cost-Effectiveness Analysis (CEA)
D
Deterministic Sensitivity Analysis
Disability-Adjusted Life-Years (DALYs)
Discrete Choice Experiment (DCE)
Discrete Event Simulation (DES)
E
Early Health Economics Modelling / Early Health Economic Assessment
Evidence-Based Procurement (EBP)
Expected Value of Partially Perfect Information (EVPPI)
Expected Value of Perfect Information (EVPI)
Expected Value of Sample Information (EVSI)
H
Health Economics and Outcomes Research (HEOR)
Health Technology Assessment (HTA)
Highly Specialised Technologies (HST)
I
Incremental Cost-Effectiveness Ratio (ICER)
Indirect Treatment Comparison (ITC)
Intention to Treat (ITT) Analysis
L
M
Managed Access Agreement (MAA)
Matching-Adjusted Indirect Comparison (MAIC)
Minimally Clinically Important Differences (MCID)
Mixed Treatment Comparison (MTC)
Multi-way Sensitivity Analysis
Multiple Technology Appraisal (MTA)
N
Negative Predictive Value (NPV)
O
P
Patient-Level Simulation Model
Patient-Reported Outcome Measures (PROMs)
Patient-Reported Outcomes (PROs)
Positive Predictive Value (PPV)
Precision Medicine / Personalized Medicine